Transforming brain surgery by advancing functional-guided neuronavigational imaging
HyperProbe is an innovative all-optical imaging system using hyperspectral imaging and AI to enhance intraoperative neuronavigation and biomarker analysis during brain tumor surgeries.
Projectdetails
Introduction
In recent years, through the advancement of imaging technologies (such as MRI, PET, CT, among others), clinical localisation of lesions of the central nervous system (CNS) pre-surgery has made it possible for neurosurgeons to plan and navigate away from functional brain locations when removing tumours.
Challenges in Neuronavigation
However, neuronavigation in the surgical management of brain tumours remains a significant challenge due to the inability to maintain accurate spatial information of lesioned and non-lesioned locations intraoperatively.
Project Overview
To answer this challenge, we have put together a team of engineers, physicists, data scientists, and neurosurgeons to develop an innovative, all-optical intraoperative imaging system based on:
- Hyperspectral imaging (HSI) for rapid, multi-wavelength spectral acquisition.
- Artificial intelligence (AI) for image reconstruction and molecular fingerprint recognition.
HyperProbe Features
Our intraoperative HSI system (HyperProbe) will:
- Map, monitor, and quantify biomolecules of interest.
- Be handheld and user-friendly.
- Apply AI-based methods for:
- The reconstruction of spectral images.
- The analysis of spatio-spectral data.
- The development and quantification of novel biomarkers.
Validation Process
We will validate the developed capacity in:
- Phantoms.
- In vivo against gold standard modalities in neuronavigational imaging.
- Finally, provide proof-of-principle during brain tumour surgery.
Project Aim
HyperProbe aims at providing functional and structural information on biomarkers of interest that is currently missing during neuro-oncological interventions.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 3.360.825 |
Totale projectbegroting | € 3.548.325 |
Tijdlijn
Startdatum | 1-10-2022 |
Einddatum | 30-9-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- UNIVERSITA DEGLI STUDI DI FIRENZEpenvoerder
- EMOLED SOCIETA A RESPONSABILITA LIMITATA
- TECHNISCHE UNIVERSITAET MUENCHEN
- UNIVERSITE LYON 1 CLAUDE BERNARD
- AZIENDA OSPEDALIERO-UNIVERSITARIA CAREGGI
- EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG
- HOSPICES CIVILS DE LYON
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- UNIVERSITY COLLEGE LONDON
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Multimodal Hypersprectal Imaging and Raman Spectroscopy for Intraoperative Assessment of Breast Tumor Resection MarginsSpectra-BREAST aims to enhance tumor margin assessment in breast conserving surgery using a novel multimodal approach for real-time, accurate feedback, improving patient outcomes and reducing reoperation rates. | EIC Pathfinder | € 2.990.207 | 2024 | Details |
Remote whole-brain functional microscopy of the vascular system: a paradigm shift for the monitoring and treatment of small vessel diseasesThe project aims to revolutionize neuroimaging by developing functional Ultrasound Localization Microscopy (fULM) for high-resolution monitoring of brain vasculature and function, enhancing disease diagnosis and treatment evaluation. | EIC Pathfinder | € 3.946.172 | 2022 | Details |
Closed-loop Individualized image-guided Transcranial Ultrasonic StimulationThe project aims to develop a neuronavigated transcranial ultrasound stimulation (TUS) system for precise, non-invasive modulation of deep brain structures to treat neurological and psychiatric disorders. | EIC Pathfinder | € 3.799.402 | 2022 | Details |
Minimally-Invasive Soft-Robot-Assisted Deep-Brain Localized Therapeutics Delivery for Neurological DisordersSoftReach aims to revolutionize neurological disorder treatments through a novel soft-growing robotic platform for localized therapeutic delivery using real-time MRI guidance. | EIC Pathfinder | € 2.158.000 | 2023 | Details |
ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGYOPTIPATH aims to revolutionize tissue diagnosis by providing real-time, non-destructive 3D imaging using advanced optical technologies and machine learning to enhance accuracy and reduce variability. | EIC Pathfinder | € 3.276.577 | 2025 | Details |
Multimodal Hypersprectal Imaging and Raman Spectroscopy for Intraoperative Assessment of Breast Tumor Resection Margins
Spectra-BREAST aims to enhance tumor margin assessment in breast conserving surgery using a novel multimodal approach for real-time, accurate feedback, improving patient outcomes and reducing reoperation rates.
Remote whole-brain functional microscopy of the vascular system: a paradigm shift for the monitoring and treatment of small vessel diseases
The project aims to revolutionize neuroimaging by developing functional Ultrasound Localization Microscopy (fULM) for high-resolution monitoring of brain vasculature and function, enhancing disease diagnosis and treatment evaluation.
Closed-loop Individualized image-guided Transcranial Ultrasonic Stimulation
The project aims to develop a neuronavigated transcranial ultrasound stimulation (TUS) system for precise, non-invasive modulation of deep brain structures to treat neurological and psychiatric disorders.
Minimally-Invasive Soft-Robot-Assisted Deep-Brain Localized Therapeutics Delivery for Neurological Disorders
SoftReach aims to revolutionize neurological disorder treatments through a novel soft-growing robotic platform for localized therapeutic delivery using real-time MRI guidance.
ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGY
OPTIPATH aims to revolutionize tissue diagnosis by providing real-time, non-destructive 3D imaging using advanced optical technologies and machine learning to enhance accuracy and reduce variability.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A Real-time imaging and classification system for low-grade glioma detection during brain surgeryThis project aims to develop a real-time imaging tool for neurosurgeons to accurately identify low-grade glioma tissue during surgery, enhancing tumor removal and improving patient outcomes. | ERC Proof of... | € 150.000 | 2022 | Details |
Transformative Pediatric Brain Cancer Imaging using Integrated Biophysics-AI Molecular MRIDevelop a novel AI-driven molecular MRI technology for rapid, noninvasive monitoring of pediatric brain cancer treatment response, enhancing precision medicine and understanding of tumor dynamics. | ERC Starting... | € 1.497.669 | 2024 | Details |
Accurate quantification of neurologic disease over timeThe project aims to develop CHRONOS, an AI-driven diagnostic tool using synthetic biomaps to enable earlier and more accurate detection of brain tumors, facilitating timely clinical decisions. | ERC Proof of... | € 150.000 | 2025 | Details |
Ontwikkeling elektronische beeldketen voor chirurgische ingrepen.PS-Medtech en I-Med technology ontwikkelen een hoofd gedragen 3D digitale microscoop om real-time 3D beelden van preoperatieve scans te integreren tijdens chirurgische ingrepen, ter verbetering van precisie en efficiëntie. | Mkb-innovati... | € 164.780 | 2018 | Details |
AI-based medical assistant - Herkennen en classificeren van tumoren m.b.v. kunstmatige intelligentieDit project ontwikkelt een geavanceerde beeldherkenningstechnologie voor realtime screening van eiwittypologieën in biopten, om de behandeling van complexe tumoren te verbeteren. | Mkb-innovati... | € 200.000 | 2018 | Details |
A Real-time imaging and classification system for low-grade glioma detection during brain surgery
This project aims to develop a real-time imaging tool for neurosurgeons to accurately identify low-grade glioma tissue during surgery, enhancing tumor removal and improving patient outcomes.
Transformative Pediatric Brain Cancer Imaging using Integrated Biophysics-AI Molecular MRI
Develop a novel AI-driven molecular MRI technology for rapid, noninvasive monitoring of pediatric brain cancer treatment response, enhancing precision medicine and understanding of tumor dynamics.
Accurate quantification of neurologic disease over time
The project aims to develop CHRONOS, an AI-driven diagnostic tool using synthetic biomaps to enable earlier and more accurate detection of brain tumors, facilitating timely clinical decisions.
Ontwikkeling elektronische beeldketen voor chirurgische ingrepen.
PS-Medtech en I-Med technology ontwikkelen een hoofd gedragen 3D digitale microscoop om real-time 3D beelden van preoperatieve scans te integreren tijdens chirurgische ingrepen, ter verbetering van precisie en efficiëntie.
AI-based medical assistant - Herkennen en classificeren van tumoren m.b.v. kunstmatige intelligentie
Dit project ontwikkelt een geavanceerde beeldherkenningstechnologie voor realtime screening van eiwittypologieën in biopten, om de behandeling van complexe tumoren te verbeteren.